Inside the AI Revolution: Isomorphic Labs’ Bold Leap with $600 Million Boost
Isomorphic Labs, a spin-off from Alphabet's DeepMind, is revolutionizing AI-powered drug discovery with $600 million in funding from Thrive Capital and Alphabet. Under Demis Hassabis's leadership, the company leverages AI…